U.S. Support Has Measurable, Lifesaving Impact

Global health investments have created remarkable progress over last two decades, with the U.S. playing a leadership role.

“The United States has a moral obligation to lead the world in confronting the pandemic of HIV/AIDS.”
— Vice President Pence, 2008 reauthorization of the U.S. global AIDS program


The Fight Against AIDS

Approximately 21.7 million people are now receiving lifesaving AIDS treatment, a significant increase from fewer than 1 million people on treatment in 2000.

Increased access to AIDS treatment and prevention programs has a drastic impact on HIV prevalence. In 2017, there were 1.8 million new HIV infections, down from 2.8 million new infections in 2000.



Tackling the Threat of TB

The TB mortality rate fell by 42 percent between 2000 and 2017. Yet, the World Health Organization ranked TB as one of the top 10 causes of death worldwide in 2017. There were an estimated 1.3 million TB deaths in 2017, and an additional 300,000 deaths from TB among people with HIV co-infection. Multi-drug resistant TB (MDR-TB) also remains a constant threat. In 2017, 457,560 people were newly eligible for MDR-TB treatment.



Progress in Preventing and Treating Malaria

While the malaria mortality rate has decreased since 2010, 435,000 people still died from malaria in 2017. Paraguay was certified as malaria-free by the WHO in 2018, and 11 countries are on track to eliminate malaria by 2020.